Drug intelligence / Profile preview

Alova

Development stage
Preclinical
Lead developer
Creative Medical Technology
Modality
Stem Cell Therapies → Cell Therapies
Administration
Injection
01

Overview

Alova is an allogeneic cell therapy developed by Creative Medical Technology Holdings, Inc., utilizing the proprietary AlloStem™ platform for the treatment of infertility resulting from premature ovarian failure (POF). The therapy is composed of Perinatal Tissue Derived Cells (PTDCs), which are scalable, "universal" donor cells that do not require patient immunosuppression. Alova aims to restore ovarian function through a multi-faceted regenerative approach, including balancing inflammatory cytokines, promoting folliculogenesis, and supporting angiogenesis within the ovarian microenvironment. It is currently in the IND-enabling phase of development and serves as an allogeneic complement to the company's autologous OvaStem® program.

Brand names
Alova
Other names
AlloStem-derived cell therapy for premature ovarian failure

Beyond the preview

Go deeper on Alova.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alova.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call